Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex P Hunyor

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Ophthalmology|April 8, 2015
Two-year outcomes of "treat and extend" intravitreal therapy for neovascular age-related macular degenerationJennifer J Arnold, Anna Campain, Daniel Barthelmes, et al.
The British Journal of Ophthalmology|March 20, 2016
Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degenerationDaniel Barthelmes, Anna Campain, Phuc Nguyen, et al.
Free Radical Biology & Medicine|September 26, 2018
Dual roles of different redox forms of complement factor H in protecting against age related macular degenerationMatthew Krilis, Miao Qi, Jian Qi, et al.
Ophthalmology|June 19, 2014
Intravitreal therapy in bilateral neovascular age-related macular degenerationDaniel Barthelmes, Richard J Walton, Jennifer J Arnold, et al.
Ophthalmology|December 3, 2014
Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumabMark C Gillies, Anna Campain, Richard Walton, et al.
The British Journal of Ophthalmology|September 25, 2014
Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study dataDaniel Barthelmes, Richard Walton, Anna E Campain, et al.
Oncotarget|February 5, 2017
Nitration of tyrosines in complement factor H domains alters its immunological activity and mediates a pathogenic role in age related macular degenerationMatthew Krilis, Miao Qi, Michele C Madigan, et al.
Ophthalmology|April 17, 2016
Bullous Variant of Central Serous Chorioretinopathy: Expansion of Phenotypic Features Using Multimethod ImagingChandrakumar Balaratnasingam, K Bailey Freund, Anna M Tan, et al.
Retina (Philadelphia, Pa.)|November 15, 2017
PERIPAPILLARY PACHYCHOROID SYNDROMENopasak Phasukkijwatana, K Bailey Freund, Rosa Dolz-Marco, et al.
Eye (London, England)|April 16, 2020
Prepapillary vascular loop-a new classificationAhmad M Mansour, Igor Kozak, Ali Osman Saatci, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Ophthalmology|April 8, 2015
Two-year outcomes of "treat and extend" intravitreal therapy for neovascular age-related macular degenerationJennifer J Arnold, Anna Campain, Daniel Barthelmes, et al.
The British Journal of Ophthalmology|March 20, 2016
Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degenerationDaniel Barthelmes, Anna Campain, Phuc Nguyen, et al.
Free Radical Biology & Medicine|September 26, 2018
Dual roles of different redox forms of complement factor H in protecting against age related macular degenerationMatthew Krilis, Miao Qi, Jian Qi, et al.
Ophthalmology|June 19, 2014
Intravitreal therapy in bilateral neovascular age-related macular degenerationDaniel Barthelmes, Richard J Walton, Jennifer J Arnold, et al.
Ophthalmology|December 3, 2014
Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumabMark C Gillies, Anna Campain, Richard Walton, et al.
The British Journal of Ophthalmology|September 25, 2014
Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study dataDaniel Barthelmes, Richard Walton, Anna E Campain, et al.
Oncotarget|February 5, 2017
Nitration of tyrosines in complement factor H domains alters its immunological activity and mediates a pathogenic role in age related macular degenerationMatthew Krilis, Miao Qi, Michele C Madigan, et al.
Ophthalmology|April 17, 2016
Bullous Variant of Central Serous Chorioretinopathy: Expansion of Phenotypic Features Using Multimethod ImagingChandrakumar Balaratnasingam, K Bailey Freund, Anna M Tan, et al.
Retina (Philadelphia, Pa.)|November 15, 2017
PERIPAPILLARY PACHYCHOROID SYNDROMENopasak Phasukkijwatana, K Bailey Freund, Rosa Dolz-Marco, et al.
Eye (London, England)|April 16, 2020
Prepapillary vascular loop-a new classificationAhmad M Mansour, Igor Kozak, Ali Osman Saatci, et al.
Pageof 6